Tom Wilton

Corporate Officer/Principal presso CARISMA THERAPEUTICS, INC.

Consumer Services

Health Technology

Profilo

Tom Wilton is currently the Chief Business Officer at LogicBio Therapeutics, Inc. and Carisma Therapeutics, Inc. He is a graduate of Brunel University, the University of Leeds, and the University of London.

Posizioni attive di Tom Wilton

Società	Posizione	Inizio
CARISMA THERAPEUTICS, INC.	Corporate Officer/Principal	01/09/2019
LOGICBIO THERAPEUTICS, INC.	Corporate Officer/Principal	-

Tutte le posizioni attive di Tom Wilton

Formazione di Tom Wilton

University of London	Undergraduate Degree
University of Leeds	Graduate Degree
Brunel University	Graduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Tom Wilton

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
CARISMA THERAPEUTICS, INC.	Health Technology

Aziende private	1
LogicBio Therapeutics, Inc. LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LogicBio Therapeutics, Inc. engages in the development of a genome editing technology platform. It focuses on the commercialization of GeneRide, which enables the site-specific integration of a therapeutic transgene without nucleases or exogenous promoters by harnessing the native process of homologous recombination. Its pipeline includes LB-001, LB-301 and LB-401. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Lexington, MA.	Health Technology